Insider Intelligence delivers leading-edge research to clients in a variety of forms, including full-length reports and data visualizations to equip you with actionable takeaways for better business decisions.
In-depth analysis, benchmarks and shorter spotlights on digital trends.
Learn More
Interactive projections with 10k+ metrics on market trends, & consumer behavior.
Learn More
Proprietary data and over 3,000 third-party sources about the most important topics.
Learn More
Industry KPIs
Industry benchmarks for the most important KPIs in digital marketing, advertising, retail and ecommerce.
Learn More
Client-only email newsletters with analysis and takeaways from the daily news.
Learn More
Analyst Access Program
Exclusive time with the thought leaders who craft our research.
Learn More

About Insider Intelligence

Our goal at Insider Intelligence is to unlock digital opportunities for our clients with the world’s most trusted forecasts, analysis, and benchmarks. Spanning five core coverage areas and dozens of industries, our research on digital transformation is exhaustive.
Our Story
Learn more about our mission and how Insider Intelligence came to be.
Learn More
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Contact Us
Speak to a member of our team to learn more about Insider Intelligence.
Contact Us
See our latest press releases, news articles or download our press kit.
Learn More
Advertising & Sponsorship Opportunities
Reach an engaged audience of decision-makers.
Learn More
Browse our upcoming and past webinars and other events.
Learn More
Tune in to eMarketer's daily, weekly, and monthly podcasts.
Learn More

What Teladoc’s Q3 earnings reveal about the future of telehealth

The news: Teladoc reported $522 million in revenues in Q3—an 81% year-over-year (YoY) spike. But its total net loss was $84.3 million in Q3 this year, which is more than double its net loss from Q3’2020.

Q3 also marked business growth for Teladoc in terms of partnerships and membership:

  • It struck new deals with CVS Health and Centene and rolled out its new primary care (Primary360) offering.
  • Total visits in Q3 went up 37% YoY, topping 3.9 million. However, its actual membership in the US only grew around 2% YoY.

The bigger picture: Telehealth use is plateauing, though it's still 38 times higher than pre-pandemic levels.

  • The volume of telehealth claims in the US has gone down from 7% in January to 4.2% in July, per Fair Health’s Monthly Telehealth Tracker.
  • That’s still around 1,750% higher than the volume of telehealth claims in January 2020 (0.24%).

And it’s not just patients who are warming up to the idea of telehealth being a permanent fixture of the healthcare ecosystem:

  • 58% of physicians view telehealth more favorably than they did pre-pandemic.
  • And 40% of consumers say they’ll continue to use telehealth in the future—up from 11% pre-pandemic, per a 2021 analysis from McKinsey.

What does the next chapter of telehealth look like? Telehealth giants like Teladoc and Amwell face pressure to be dethroned by growing competitors like Amazon Care, Hims & Hers, and Ro.

  • Amazon Care only just launched its virtual care service to employer customers nationwide, and it’s already expanding to in-person home care visits in 20 major cities as of September.
  • And direct-to-consumer companies like Hims & Hers and Ro are doubling down on their patient-centric branding, partnering with retailers, and branching into different telehealth specialties (like dermatology, mental health, diagnostics, and pharmacy).

Nontraditional telehealth entrants are coming out of the woodwork—and they come with new consumer appeal:

  • For example, 23andMe recently acquired Lemonaid to merge its genetic insights capabilities with telehealth to bring precise and personalized healthcare to its consumers.

The big takeaway: Altogether, this competitive landscape could push telehealth giants like Teladoc and Amwell to potentially partner with or acquire a telehealth company that focuses on a high-cost/demand specialty like musculoskeletal care firm Hinge Health or digital diabetes management firm Virta Health.